Kalyani Steels Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:32 am

Competitors of Kalyani Steels Ltd

All Competitor Stocks of Kalyani Steels Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:35 pm

Below is a detailed analysis of the quarterly data for Kalyani Steels Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 443.00 Cr.. The value appears to be declining and may need further review. It has decreased from 544.00 Cr. (Mar 2025) to 443.00 Cr., marking a decrease of 101.00 Cr..
• For Expenses, as of Jun 2025, the value is 357.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 430.00 Cr. (Mar 2025) to 357.00 Cr., marking a decrease of 73.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 85.00 Cr.. The value appears to be declining and may need further review. It has decreased from 114.00 Cr. (Mar 2025) to 85.00 Cr., marking a decrease of 29.00 Cr..
• For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 19.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2025) to 82.00 Cr., marking a decrease of 25.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 61.00 Cr., marking a decrease of 18.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.97. The value appears to be declining and may need further review. It has decreased from 18.16 (Mar 2025) to 13.97, marking a decrease of 4.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:03 am

Growth

Last Updated: September 5, 2025, 8:45 am

Balance Sheet

Last Updated: November 9, 2025, 2:20 pm

Below is a detailed analysis of the balance sheet data for Kalyani Steels Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,948.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,883.00 Cr. (Mar 2025) to 1,948.00 Cr., marking an increase of 65.00 Cr..
• For Borrowings, as of Sep 2025, the value is 428.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 438.00 Cr. (Mar 2025) to 428.00 Cr., marking a decrease of 10.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 424.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 403.00 Cr. (Mar 2025) to 424.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,821.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,745.00 Cr. (Mar 2025) to 2,821.00 Cr., marking an increase of 76.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 652.00 Cr.. The value appears to be declining and may need further review. It has decreased from 678.00 Cr. (Mar 2025) to 652.00 Cr., marking a decrease of 26.00 Cr..
• For CWIP, as of Sep 2025, the value is 490.00 Cr.. The value appears strong and on an upward trend. It has increased from 429.00 Cr. (Mar 2025) to 490.00 Cr., marking an increase of 61.00 Cr..
• For Investments, as of Sep 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 13.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,541.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,487.00 Cr. (Mar 2025) to 1,541.00 Cr., marking an increase of 54.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,821.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,745.00 Cr. (Mar 2025) to 2,821.00 Cr., marking an increase of 76.00 Cr..

Notably, the Reserves (1,948.00 Cr.) exceed the Borrowings (428.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Kalyani Steels Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from 56.99 (Mar 24) to 58.70, marking an increase of 1.71.
• For Diluted EPS (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from 56.99 (Mar 24) to 58.70, marking an increase of 1.71.
• For Cash EPS (Rs.), as of Mar 25, the value is 73.10. This value is within the healthy range. It has increased from 70.79 (Mar 24) to 73.10, marking an increase of 2.31.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 432.55. It has increased from 384.18 (Mar 24) to 432.55, marking an increase of 48.37.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 432.55. It has increased from 384.18 (Mar 24) to 432.55, marking an increase of 48.37.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 453.23. It has increased from 448.11 (Mar 24) to 453.23, marking an increase of 5.12.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 97.94. This value is within the healthy range. It has increased from 95.55 (Mar 24) to 97.94, marking an increase of 2.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is 83.44. This value is within the healthy range. It has increased from 81.66 (Mar 24) to 83.44, marking an increase of 1.78.
• For PBT / Share (Rs.), as of Mar 25, the value is 79.20. This value is within the healthy range. It has increased from 76.18 (Mar 24) to 79.20, marking an increase of 3.02.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 58.60. This value is within the healthy range. It has increased from 56.89 (Mar 24) to 58.60, marking an increase of 1.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.60. This value is within the healthy range. It has increased from 56.89 (Mar 24) to 58.60, marking an increase of 1.71.
• For PBDIT Margin (%), as of Mar 25, the value is 21.60. This value is within the healthy range. It has increased from 21.32 (Mar 24) to 21.60, marking an increase of 0.28.
• For PBIT Margin (%), as of Mar 25, the value is 18.41. This value is within the healthy range. It has increased from 18.22 (Mar 24) to 18.41, marking an increase of 0.19.
• For PBT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 16.99 (Mar 24) to 17.47, marking an increase of 0.48.
• For Net Profit Margin (%), as of Mar 25, the value is 12.92. This value exceeds the healthy maximum of 10. It has increased from 12.69 (Mar 24) to 12.92, marking an increase of 0.23.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.92. This value is within the healthy range. It has increased from 12.69 (Mar 24) to 12.92, marking an increase of 0.23.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.54. This value is below the healthy minimum of 15. It has decreased from 14.80 (Mar 24) to 13.54, marking a decrease of 1.26.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.77. This value is within the healthy range. It has decreased from 19.92 (Mar 24) to 18.77, marking a decrease of 1.15.
• For Return On Assets (%), as of Mar 25, the value is 9.37. This value is within the healthy range. It has decreased from 9.66 (Mar 24) to 9.37, marking a decrease of 0.29.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has decreased from 0.35 (Mar 24) to 0.23, marking a decrease of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.74. It has increased from 0.00 (Mar 24) to 0.74, marking an increase of 0.74.
• For Current Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.76 (Mar 24) to 1.95, marking an increase of 0.19.
• For Quick Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from 1.39 (Mar 24) to 1.57, marking an increase of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.76. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.76, marking an increase of 6.76.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.03. This value is below the healthy minimum of 20. It has decreased from 17.54 (Mar 24) to 17.03, marking a decrease of 0.51.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.65. This value is below the healthy minimum of 20. It has decreased from 14.10 (Mar 24) to 13.65, marking a decrease of 0.45.
• For Earning Retention Ratio (%), as of Mar 25, the value is 82.97. This value exceeds the healthy maximum of 70. It has increased from 82.46 (Mar 24) to 82.97, marking an increase of 0.51.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.35. This value exceeds the healthy maximum of 70. It has increased from 85.90 (Mar 24) to 86.35, marking an increase of 0.45.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 23.07. This value is within the healthy range. It has increased from 16.19 (Mar 24) to 23.07, marking an increase of 6.88.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.80. This value is within the healthy range. It has increased from 10.57 (Mar 24) to 14.80, marking an increase of 4.23.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,023.84. It has decreased from 3,779.81 (Mar 24) to 3,023.84, marking a decrease of 755.97.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has decreased from 1.93 (Mar 24) to 1.53, marking a decrease of 0.40.
• For EV / EBITDA (X), as of Mar 25, the value is 7.06. This value is within the healthy range. It has decreased from 9.05 (Mar 24) to 7.06, marking a decrease of 1.99.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 1.91 (Mar 24) to 1.68, marking a decrease of 0.23.
• For Retention Ratios (%), as of Mar 25, the value is 82.96. This value exceeds the healthy maximum of 70. It has increased from 82.45 (Mar 24) to 82.96, marking an increase of 0.51.
• For Price / BV (X), as of Mar 25, the value is 1.76. This value is within the healthy range. It has decreased from 2.22 (Mar 24) to 1.76, marking a decrease of 0.46.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 1.91 (Mar 24) to 1.68, marking a decrease of 0.23.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness